With the approach of Thanksgiving, I’d like to reflect on several of the association’s recent accomplishments and recognize the firms and individuals responsible for these successes. First and foremost, I want to thank our entrepreneurs and our community partners that participated in this year’s informative Knowledge Fair & Expo that was held at CNM’s Workforce Training Center. We owe a major thank you to our sponsors, especially to the Pharmaceutical Research and Manufacturers of America (PhRMA) for being the title sponsor for the event. In addition to getting progress updates on their research, discoveries and achievements from the founders and CEOs of many of New Mexico’s most innovative life science firms – NTx, Spartina Biotechnologies, Pebble Labs, Prosel Biosciences, Bright Path Labs, BioFlyte, Inc., Sandia Biotech, T-Neuro Pharma, Circular Genomics, Fab Lab Hub — we enjoyed the presentations of two distinguished keynote speakers that truly captured our attention:
- Dr. Douglas Ziedonis, Executive Vice President for UNM Health Sciences and CEO of the UNM Health Systems discussed how Covid is bringing major changes to the healthcare industry as well as a series of initiatives being undertaken by UNM-HSC, including the expansion of its physical facilities and telehealth programs.
- Hannah Green, Senior Director of Advocacy and Strategic Alliances for PhRMA, discussed “Innovation, Investment and Partnerships in New Mexico.” She also discussed how PhRMA is working to drive Patient centered progress in innovation, affordability and access to life saving prescription drugs.
Other kudos go to behind the scenes members that supported the event, in particular, Wayne Savage for arriving early and covering the registration desk as well as helping me arrange tables for the exhibitors, TJ Cook for helping us secure space at CNM’s facility, Rick VanNess for overseeing our audio visual needs, the Delmarva Group’s JT Koffenberger for enhancing and distributing our marketing materials, Sue Prelozni for helping create the sponsorship slides, Bethany Gravell of the Kenney Group for helping us recruit Hannah Green and to Elizabeth Kuuttila for connecting us to Dr. Ziedonis.
In addition to our signature event, three of our members – Alex Koglin, Michelle Miller and Paul Laur, and I were able to give a presentation on the growth NM’s bioscience sector and the contributions of their firms to that growth at the NM Technology Council’s recent marque event. We owe a thank you to Deborah Breitfeld, the association’s president, for the invitation and the opportunity for me to man an exhibit table at its event (gratis). Deborah and I are constantly looking for ways that we can collaborate, including marketing each other’s events to our respective members.
In other news, the board and I want to congratulate Paul Laur, founder of Spartina Biotechnologies and Sarah Boisvert, founder of Fab Lab Hub (and several other initiatives), on their appointments to the New Mexico Bioscience Authority’s Board of Directors. As a member of BSA’s board since its inception, I was delighted to recommend them and know that they will be significant contributors to the state’s first public-private non-profit. Paul also serves on NMBio’s board of directors.
Healthy regards,
Greg Byrnes
Executive Director
NMBio
610-731-3671 (M)
vCard |
|
BIO is Accepting Company Presentations for the 2022 BIO International Convention, June 13-16, San Diego
Company Presentations are a great way to increase your visibility at the BIO International Convention, especially in BIO One-on-One Partnering and attracting more partners to meet. These 13-minute podium presentations allow you to tell your company’s story and advance your business development goals. Applications are accepted for review and approval through May 27 or when spots sell out. |
|
Connecting Companies to Capital
The Rocky Mountain Life Science Investor & Partnering Conference will return in September,2022! To receive conference updates, please email the Director of Partnerships, Tracey Nilson. Investors and strategic partners converge in the Colorado mountains on a biennial basis to learn about new breakthroughs coming out of the Rocky Mountain region.
Colorado BioScience Association leads the biennial event, attracting high-profile angel investors, venture capitalists, and representatives from large life sciences companies to meet leaders from emerging and established life science companies from Arizona, Colorado, Montana, New Mexico and Utah.
The dynamic event offers investors and companies the opportunity to get to know each other through formal presentations and informal networking sessions in a relaxed mountain environment. Regional Partners: AZ Bio, NMBio, BioUtah and the Montana BioScience Alliance
|
|
Navigating Non-Dilutive Funding
Government to Growth (G2G) is led by Liz Powell, Esq., MPH, and includes a team of government affairs professionals who help startups, businesses and non-profits effectively navigate non-dilutive federal funding opportunities. With a specialty focus on life sciences, G2G tracks grants on a daily basis and produces a monthly GBG Report listing all bioscience funding opportunities. G2G has also produced The Essential Guide to Coronavirus Government Funding – an extensive resource for government funding to address the pandemic.
G2G has obtained over $277 million in non-dilutive government funding since 2007 and developed relationships with the White House, Congress, and federal agencies, including the Departments of Defense, Health and Human Services, and Homeland Security
|
|
The National Institute on Aging (NIA) offers early-stage funding to small businesses looking to commercialize innovative treatments to help people enjoy healthier lives as they age. NIA participates in the annual NIH SBIR contracts solicitation, which aims to spur development of specific innovations, including Alzheimer’s and related dementias, chronic wound treatment, regeneration of aging tissues, and more.
Learn more about open SBIR/STTR funding opportunities. The next deadline to apply is January 5, 2022. |
|
RESI Partnering Week: November 16 – November 18
 The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
|
|
BioTech Showcase
Jan. 17 – 19, 2022 – Virtual
Jan. 10 – 12, 2022 – In-person, San Francisco, CA
It’s up to you if you want to join in person or digitally. Either way, Biotech Showcase will give you the opportunity to re-connect with your peers via seamless one-to-one networking in partneringONE®.
Hear the latest industry trends in workshops and panels featuring key biotech leaders, investors, pharma executives, and other industry advisors.
|
|
The New Mexico EDD Issues JTIP Awards to Bennu Bio and BioFlyte
BennuBio, Inc. is a growing Albuquerque biotechnology startup that provides valuable cellular and particle diagnostic instrumentation for markets that include biomedical diagnostic via flow cytometry. Their technology can help researchers better identify which biological samples warrant further testing and their three-dimensional models play an important role in personalized medicine, cancer, and immunotherapy research. Total trainees: 7; Average hourly wage: $32.43; JTIP award amount approved: $121,258
BioFlyte, Inc., Albuquerque, is a biodefense and microbial identification company that is commercializing a revolutionary new class of fieldable biological contamination sampling, detection, and identification solutions. The firm’s current application focus is critical infrastructure protection and pandemic response. Total trainees: 7; Average hourly wage: $32.43; JTIP award amount approved: $121,258 |
|
 ALT is a full-service provider of premium refurbished lab equipment and surplus strategy services for the life sciences. With more than 12,000 instruments in stock ranging from small benchtop accessories to robust triple quad mass spectrometers – all items are carefully refurbished and delivered with a one-year warranty. ALT also purchases, consigns, trades, or auctions your surplus equipment to monetize your assets and maximize your ROI. To learn more about ALT’s updated benefits, click here. |
|
|
To Top
